Intrinsiqs

Is Cumberland Pharmaceuticals Inc. overvalued?

Cumberland Pharmaceuticals Inc. (CPIX) — key valuation metrics and fundamentals.

No verdict
Price
$5.88
Fair value
—
Current P/E
—
Normal P/E
42.1
Market cap
$88.1M
Dividend yield
23.1%
Return on equity
202.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CPIX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.